Terms ending in 2038
Every in-force patent on Juno, Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,379,375 | Methods for Assessing Cell Surface Glycosylation In force · High confidence | Juno Therapeutics, Inc. | In force | High confidence | |
| US 11,944,647 | Articles of Manufacture and Methods for Treatment Using Adoptive Cell Therapy In force · High confidence | Juno Therapeutics, Inc. | In force | High confidence | |
| US 12,583,904 | Articles of Manufacture and Methods for Treatment Using Adoptive Cell Therapy In force · High confidence | Juno Therapeutics, Inc. | In force | High confidence | |
| US 12,215,348 | Methods for Producing Genetically Engineered Cell Compositions and Related Compositions In force · High confidence | Juno Therapeutics, Inc. | In force | High confidence | |
| US 10,832,368 | Methods and Systems for Navigating Drivers to Passengers Based on Trustworthiness Ratings In force · High confidence | Lyft, Inc. | In force | High confidence | |
| US 10,645,193 | System for Placing Drivers in a Priority Queue and Navigating the Drivers to Fullfill Passenger Requests In force · High confidence | Lyft, Inc. | In force | High confidence | |
| US 12,087,166 | Preemptively Navigating Drivers to an Event Location to Transport Passengers Upon Completion of the Event In force · Medium confidence | Lyft, Inc. | In force | Medium confidence | |
| US 11,847,862 | System for Directing a Transporation Request to a Driver with an Inactive Status Based on Exception Criteria In force · High confidence | Lyft, Inc. | In force | High confidence | |
| US 12,168,027 | Methods Associated with Tumor Burden for Assessing Response to a Cell Therapy In force · Medium confidence | Juno Therapeutics, Inc. | In force | Medium confidence | |
| US 11,815,514 | Methods and Compositions Related to Toxicity Associated with Cell Therapy In force · High confidence | Juno Therapeutics, Inc. | In force | High confidence | |
| 2 more term ends in 2038 · Pro | |||||
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
7 of these are in force and held by Juno, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.